Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure

2011 ◽  
Vol 94 (1) ◽  
pp. 119-125 ◽  
Author(s):  
Charlotte Andersson ◽  
Gunnar H. Gislason ◽  
Casper H. Jørgensen ◽  
Peter R. Hansen ◽  
Allan Vaag ◽  
...  
Keyword(s):  
Heart Failure ◽  
Mortality Risk ◽  
Patients With Heart Failure ◽  
Long Term Mortality ◽  
Diabetes Patients

scholarly journals Long-term mortality risk in hospitalized patients with heart failure after myocardial infarction

2020 ◽  
Vol 25 (1) ◽  
pp. 14-18
Author(s):  
A. S. Galyavich ◽  
I. M. Mingalimova ◽  
Z. M. Galeeva ◽  
L. V. Baleeva
Keyword(s):  
Risk Factors ◽  
Myocardial Infarction ◽  
Heart Failure ◽  
Mortality Risk ◽  
Mortality Risks ◽  
Patients With Heart Failure ◽  
D Dimer ◽  
Long Term Mortality

Aim. Comparative assessment of laboratory and instrumental parameters of patients with heart failure (HF) after myocardial infarction at admission and discharge from the hospital to determine the long-term mortality risk.Material and methods. The clinical outcomes of 117 patients with stage II-III  (Strazhesko-Vasilenko Classification) heart failure (64 men and 53 women) were studied. All patients admitted to the hospital underwent laboratory and instrumental examination. The average follow-up for patients after discharge from the hospital was 3 years (12 to 44 months). The long-term mortality risks of HF patients were compared according to the examination data upon admission and discharge from the hospital.Results. The long-term mortality risk factors of HF patients at admission are the levels of pro-brain natriuretic peptide (proBNP) (risk 1,08, p=0,001), D-dimer (risk 1,062, p=0,018), urea (risk 1,048, p=0,016), creatinine (risk 1,006, p=0,016), alanine transaminase (risk 1,002, p=0,009). The long-term mortality risk factors of HF patients at discharge are urea (risk 1,141, p=0,001), N-terminal proBNP (risk 1,101, p=0,002), and the number of neutrophils (risk 1,064, p=0,002).Conclusion. There is a difference in risk factors for long-term mortality risk of HF patients at admission and discharge from the hospital.

Effects of Spironolactone on Long-term Mortality and Morbidity in Patients With Heart Failure and Mild or No Symptoms

2014 ◽  
Vol 347 (4) ◽  
pp. 271-276 ◽  
Author(s):  
Enrico Vizzardi ◽  
Savina Nodari ◽  
Giorgio Caretta ◽  
Antonio D'Aloia ◽  
Natalia Pezzali ◽  
...  
Keyword(s):  
Heart Failure ◽  
Mortality And Morbidity ◽  
Patients With Heart Failure ◽  
Long Term Mortality

Relation of Blood Urea Nitrogen to Long-Term Mortality in Patients With Heart Failure

2008 ◽  
Vol 101 (11) ◽  
pp. 1643-1647 ◽  
Author(s):  
Clay A. Cauthen ◽  
Michael J. Lipinski ◽  
Antonio Abbate ◽  
Darryn Appleton ◽  
Annunziata Nusca ◽  
...  
Keyword(s):  
Heart Failure ◽  
Blood Urea Nitrogen ◽  
Urea Nitrogen ◽  
Patients With Heart Failure ◽  
Long Term Mortality
Sign in / Sign up

Export Citation Format

Share Document